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Methods
In this paper we assess the prevalence of inconsistency from data of 40 published networks of interventions involving 303 loops of evidence. Inconsistency is evaluated in each loop by contrasting direct and indirect estimates and by employing an omnibus test of consistency for the entire network. We explore whether different effect measures for dichotomous outcomes are associated with differences in inconsistency, and evaluate whether different ways to estimate heterogeneity affect the magnitude and detection of inconsistency.
Results
Inconsistency was detected in from 2% to 9% of the tested loops, depending on the effect measure and heterogeneity estimation method. Loops that included comparisons informed by a single study were more likely to show inconsistency. About one-eighth of the networks were found to be inconsistent. The proportions of inconsistent loops do not materially change when different effect measures are used. Important heterogeneity or the overestimation of heterogeneity was associated with a small decrease in the prevalence of statistical inconsistency.
Introduction
To inform health-care decision making, the comparison of many relevant interventions is required. A commonly encountered problem in evaluating the efficacy of multiple interventions is the lack of trials (or a paucity of available trials) that directly compare the interventions of interest. In such cases indirect evidence can be used, via a common comparator.
Bucher et al. were early proponents of the use of indirect evidence in meta-analysis when head-to-head evidence is not available. 1 The application of indirect comparison rests on the assumption of transitivity, requiring that pairwise comparisons be similar in factors that could affect the relative treatment effects.
An extension of conventional meta-analysis is network meta-analysis. Network meta-analysis is used to combine the results of clinical trials that undertake different comparisons of treatments. [2] [3] [4] [5] The method involves the simultaneous analysis both of direct comparisons within trials and indirect comparisons across trials. When combining the results of direct and indirect comparisons, the extent to which these results are consistent (in agreement) with each other should be examined. Network meta-analysis is most justifiable under an assumption of consistency between different sources of evidence. The evaluation of inconsistency of evidence is therefore an important aspect of network meta-analysis. In a network of treatments, different pairwise comparisons can form evidence cycles, also called loops, within which inconsistency can be evaluated. 6 Empirical studies have examined the prevalence of inconsistency in direct vs. indirect comparisons. Song et al. 7, 8 conducted an empirical study applying the Bucher method and assuming different parameters of heterogeneity in every comparison within each loop. They evaluated inconsistency in 112 loops of evidence formed by studies comparing pairs of three treatments, and concluded that inconsistency was detected in 14% of the networks. 8 In a response to comments on their article, Song et al. alternatively assumed that all comparisons within each triangular loop shared the same amount of heterogeneity, and observed that this reduced inconsistency to 12%. 9 However, no empirical evidence exists about the prevalence of inconsistency in more complex networks, primarily because no omnibus test was available until recently to evaluate the assumption of consistency in a network as a whole. A general model for detecting inconsistency, called a designby-treatment-interaction model, has been proposed. 10 Inconsistency can be viewed not only as the disagreement between direct and indirect estimates in a loop, but also as the disagreement between studies involving different sets of treatments.
In a network of trials, the detection of inconsistency can be hampered by the presence of heterogeneity. A large variance in the heterogeneity of treatment effects leads to greater uncertainty in estimates of the mean effect sizes, and statistical inconsistency is less likely to be detected. The estimation of the variance in heterogeneity can vary with different methods (e.g. method of moments proposed by DerSimonian and Laird, 11 restricted maximum likelihood 12 ), which subsequently affects the ability to detect inconsistency. Assumptions about heterogeneity being the same in different parts of a network or the same throughout an entire network may similarly affect the detection of inconsistency. However, because factors that cause heterogeneity can also cause inconsistency, complete separation of the two is not always possible. In summary, a great degree of heterogeneity increases the likelihood of inconsistency but decreases the chance of detecting it.
The use of different effect measures can influence both the presence and the detection of inconsistency. Empirical studies have shown that ratio measures [odds ratios (ORs) and risk ratios (RRs)] are less heterogeneous than are absolute effect measures (e.g. the risk difference (RD)) and that the RR for adverse outcomes is less likely to be heterogeneous than that for beneficial outcomes. 13, 14 These differences depend on the extent of variation in baseline risk across studies. If baseline risks are substantially different in different parts of a loop, then the underlying inconsistency may be greater for some effect measures than for others; if baseline risks vary substantially within each comparison, then more or less heterogeneity may be present, depending on the effect measure, with the same consequences as discussed in the previous paragraph. Caldwell et al. have considered the choice of effect measure to be used in a network meta-analysis and concluded that this choice should be based on physiological understanding of the outcome and, if possible, after consideration of the fit of the model. 15 The aim of this paper is to evaluate empirically the prevalence of inconsistency in published networks of interventions that compare at least four treatments, and to examine the extent to which this prevalence is acknowledged by the investigators who conduct meta-analyses. A further aim is of the paper to investigate the statistical considerations that might influence the statistical detection of inconsistency in these complex networks of evidence. We also explore whether different effect measures for dichotomous outcome data are associated with differences in inconsistency, and whether different ways of estimating heterogeneity affect the magnitude and detection of inconsistency.
Methods
To assess inconsistency in a network, we use two methods. The first method evaluates inconsistency in all closed loops of evidence formed by three or four treatments within each network, by contrasting direct with indirect estimates of a specific treatment effect. Bucher et al. described this method in an early paper, 1 and we will refer to it and its extensions used in this paper as the 'loop-specific approach'. The second method evaluates whether a network as a whole demonstrates inconsistency through the use of an extension of multivariate meta-regression that allows for different treatment effects in studies with different designs (the 'design-by-treatment interaction approach'). 10 As an example of the idea of
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the design-by-treatment-interaction approach, one can consider a network of evidence constructed from an ABC three-arm trial and an ABCD four-arm trial. Both ABC and ABCD trials are inherently consistent. However, the two studies are considered to have different designs, and design inconsistency reflects the possibility that they might give different estimates for the same comparisons they make (AB, AC and BC).
We chose the loop-based approach because it is simple and can be easily applied without specialised software in a frequentist setting, and is so far the most commonly applied approach. Moreover, the results obtained from this method can be compared directly with findings from other empirical studies. 8 We chose the design-by-treatment-interaction approach because it is the only approach of which we are aware that does not require arbitrary assumptions about the inclusion of trials with more than two treatment arms. It provides a generalization to the method earlier proposed by Lu and Ades. 6 Both the loop-specific and the design-by-treatment-interaction approaches are used under various effect measures for dichotomous outcome data and various estimators for the heterogeneity variance.
Loop-specific approach Inconsistency can be evaluated as the disagreement between different sources of evidence within a closed loop. In each network of treatments we identified all triangular loops (closed paths involving three different treatments) as well as all quadrilateral loops (closed paths involving four different treatments). We first estimate treatment effects of all pairwise comparisons in each loop by using standard meta-analysis. Consider, for example, the triangular loop ABC formed by treatments A, B, C with available comparisons AB, AC and BC. Let y i, AB be the observed effect size (e.g. logarithm of the OR) of treatment B relative to treatment A in study i, with an estimated variance v i, AB . Under the random-effects model the observed treatment effect y i, AB is modeled as
where AB is the mean of the distribution of the underlying effects of B relative to A, i, AB is a random effect for study i and " i, AB is the within-study sampling error. Similarly, for the other two comparisons in the loop:
To estimate all direct relative effects within the triangular loop ABC, we performed a random-effects meta-analysis for each available comparison. Under the random-effects model it is assumed that 
We define a loop as statistically inconsistent when z j j>1:96.
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A similar process is followed for all quadrilateral loops formed by four different head-to-head comparisons. However, if the quadrilateral loop is formed by two or more triangles, then only the triangles are evaluated. Because a multi-arm study is inherently consistent in an evidence loop, it causes complications, and we therefore exclude the comparison that is most frequent within the loop. This can affect the summary treatment effects and subsequently the evaluation of inconsistency for a network with many multi-arm studies.
The loop-specific approach was done with software R 2.13.2, 18 using the ifplot.fun function, which is available online (http://www.mtm.uoi.gr/ under How to do an MTM).
Design-by-treatment-interaction approach Loop inconsistency refers to a difference between direct and indirect estimates for the same comparison. However, the presence of multi-arm trials in a network of evidence complicates the evaluation of loop inconsistency because loops formed within multi-arm trials are necessarily consistent. Consider, for example, a network comprising some AB studies, some AC studies and some three-arm ABC studies. Note that only two of the three possible treatment effects are sufficient to fully specify the results of the three-arm studies. If the two effects include the BC comparison, then loop inconsistency might be observed by contrasting it with an indirect estimate constructed from the other two groups of studies. On the other hand, if the two effects from the three-arm studies are AB and AC, then an evaluation of inconsistency would not take place. To overcome these problems, a different type of inconsistency has been proposed, known as design inconsistency. This refers to the differences in the estimated effect sizes for the same comparison from studies that involve different sets of treatments. The design-by-treatment-interaction model is an extension of the previous approach that assesses not only loop inconsistency but also design inconsistency.
Consider a network consisting of treatments in the set T ¼ A, B, C, D, :::
f gincluding different studies that compare subsets of T named 'designs' and denoted by des ¼ 1, . . . ,Des. Let T des , with T des 2 T, define the set of treatments in design des. The dataset includes in total N studies, where each design des is present in n des studies indexed i ¼ 1, ::: , n des .
The network meta-analysis model is defined as a multivariate random-effects meta-analysis. Assume that A is an arbitrarily chosen reference treatment and T is some treatment in the set T des ¼ B, C, D, ::: f g . The observed effect size y des, i, AT of treatment T relative to that of treatment A of study i with design des is modelled under the consistency assumption as
The inconsistency model is an extension of model (1) and is defined as a multivariate random-effects meta-regression with additional covariates for the different designs:
where IF des, AT represents inconsistency in comparison AT for design des, which may correspond to either design inconsistency or loop inconsistency. As described in detail elsewhere, 19, 20 not all possible IF des, AT covariates are required, because if they are, the model is overparameterised. For designs that do not include the reference treatment, a data augmentation technique is applied. 10 This is basically imputing data for arm A that contains a very small amount of information, such as 0.08 successes in 0.1 individuals. The study random errors are normally distributed " des, i $ N 0, S i ð Þ, where S i is the within-study variance-covariance matrix.
where S is the between-studies variance-covariance matrix involving the heterogeneity variance for each treatment comparison. We discuss the structure of S in the Estimation of the heterogeneity section.
If a design-by-treatment-interaction model has l independent inconsistency parameters, then under the null hypothesis, 
We estimated inconsistency by fitting model (2) in STATA using the mvmeta command.
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The design-by-treatment-interaction approach estimates inconsistency in the entire network, whereas the loop-specific approach evaluates each loop separately. It is therefore impossible to infer about the level of agreement between the two methods. In order to describe how the two methods perform, we arbitrarily considered a network to be inconsistent under the loop-specific approach if at least 5% of its loops are inconsistent.
Effect measures
We restrict our investigation of inconsistency to dichotomous outcomes. We consider four effect measures; the OR, the RD, the risk ratio of beneficial outcomes (RRB) and the risk ratio for harmful outcomes (RRH). It has been shown that the choice of the effect measure can affect the heterogeneity variance, 13, 14 which subsequently might affect the estimation of inconsistency.
Estimation of heterogeneity
Let us define as 2 XY the heterogeneity in the X vs. Y comparison. We made assumptions about these heterogeneity variances, and we address first the loop-specific approach. Consider the network defined by two triangular loops, ABC and BCD, informed by AB, AC, BC, BD and CD comparisons. Heterogeneity might be present in each comparison, and the amount of heterogeneity is estimated either by considering the loop to which the comparison belongs (common within-loop heterogeneity) or by considering the entire network (common within-network heterogeneity). Under the common within-loop heterogeneity ( 2 loop ) approach, all comparisons in a particular loop have the same amount of heterogeneity; ABC loop:
Assuming a common within-loop heterogeneity allows comparisons that have been addressed by only one study to 'borrow strength' from the rest of the comparisons included in the loop. When all comparisons involved in a loop are informed by a single study, we set 2 loop equal to zero. Note that in our analyses, 2 loop may be different for the same comparison when it is involved in different loops.
In the design-by-treatment-interaction model, we assume that all comparisons in the network share the same heterogeneity variance (common withinnetwork heterogeneity), i.e.
Suppose thar the total number of treatments included in a network is p; the variance-covariance matrix for the random effects is therefore given by
In general, when the number of studies included in a meta-analysis is large, the heterogeneity parameter is more precisely estimated. 21 Therefore, it is likely that 2 ntw is more precise than 2 loop . Assuming a common heterogeneity variance also affects the precision of the summary effects, and consequently affects the power for detecting inconsistency. For example, it is possible that the heterogeneity in a specific loop ABC is smaller than the heterogeneity in the rest of the network. Assuming the same heterogeneity in the network will then decrease precision for the summary estimates of the ABC loop and may therefore decrease the power to detect inconsistency. Similarly, assuming a common within-network heterogeneity introduces heterogeneity in loops involving comparisons informed by a single study, decreasing the chance of identifying the presence of inconsistency. Although the assumption of a common within-network heterogeneity can underestimate the prevalence of substantial inconsistency, it allows a more accurate representation of how the effects are being combined in a network meta-analysis.
The heterogeneity variance ( 2 ) can be estimated with a variety of methods. 22 The performance of the different estimators can differ in terms of bias and mean squared error (MSE), and they can over-or under-estimate the true heterogeneity variance. As heterogeneity may affect the estimation of inconsistency, we evaluate inconsistency under different estimators of 2 . We apply the different estimation methods under the OR measure. In the loop-based approach we used the DerSimonian and Laird (DL) 22, 11 restricted maximum likelihood (REML) 22, 23 and the Sidik-Jonkman (SJ) 24 methods. We include the DL method because it is frequently used in random-effects meta-analysis and is the default estimator in rhe STATA metan command 25 and RevMan. 26 The DL estimator performs well for small values of 2 but underestimates the true heterogeneity variance when 2 is large or the number of studies is relatively small, producing a large negative bias. 24, 27, 28 The popular REML method is less biased than the DL method (except for small values of 2 for which the methods are comparable), 12, 29 but underestimates 2 when data are sparse. 29, 30 The less popular SJ estimator has been shown to overestimate 2 when the true heterogeneity variance is relatively small. 31 The SJ method is one of the best methods when the true heterogeneity variance is large, producing little bias that is substantially smaller than with the DL estimator. 12, 24 Among the three estimators the DL method is less variable in terms of the MSE in meta-analyses with small to moderate heterogeneity. 12 In the design-by-treatment-interaction model, only DL, maximum likelihood (ML) 22, 32 and REML 22, 23 estimators of D are available. We apply the ML and REML methods, since the DL method is not appropriate when the augmentation technique is used. 20 The ML method underestimates 2 when the number of studies is small or moderate, producing a relatively large degree of negative bias. 12, 23 It has been shown that the REML method is less biased with larger MSE than is the ML method.
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Other methods to evaluate inconsistency In addition to those discussed above, several other methodologies for evaluating consistency have been outlined in the literature (for a review see NICE DSU Technical Support Document 4 33 ). The methods can be broadly categorised into methods that contrast direct and indirect evidence for a particular comparison within a network (as does the loop-specific approach outlined above) and methods that evaluate inconsistency in a network as a whole (such as the design-by-treatment-interaction model). Methods in the former category are useful for locating sources of inconsistency, whereas methods in the latter category provide global tests.
A drawback of the loop-based method is that inferences in loops are not independent, because different loops of a network share the same studies. To overcome this, Caldwell et al. 34 introduced a chi-squared test for the special case in which all loops in a network share a single comparison. However, this can be applied only to specific parts of the network, and again yields multiple tests if all pieces of the network need to be tested. Another drawback of the loop-based approach is that indirect evidence is restricted to the information provided from a single loop. It is preferable to compare the direct evidence with the indirect estimate from the entire network, as is also the approach taken in the node-splitting method proposed by Dias et al. 35 The node-splitting approach is computationally intensive, and to our knowledge has not yet been automated, making it impractical for large networks. All three methods outlined above are sensitive to the parameterization of multi-arm studies, and do not offer obvious ways for making inferences about network consistency. Among all of the methods for evaluating inconsistency, the loop-based approach, despite its shortcomings, has to date been the most popular approach to evaluating inconsistency.
When network meta-analyses are fit within a Bayesian framework, investigators often contrast models with and without the consistency constraints with respect to fit and parsimony. 36 This provides a global test for the plausibility of consistency in the entire network, but inferences are again sensitive to the parameterization of multi-arm studies. The design-by-treatment-interaction model is the only method that provides an omnibus test, can be fit in a frequentist setting, and provides results insensitive to the parameterisation of multi-arm studies. 19, 20 Models that do not account for design inconsistency (such as those presented in Lu and Ades 37 and Lumley 38 ) are special cases of the design-bytreatment-interaction model.
Searching for network meta-analyses and data extraction
The search code we used was '(network OR mixed treatment* OR multiple treatment* OR mixed comparison* OR indirect comparison* OR umbrella OR simultaneous comparison*) AND (meta-analysis)'. We extracted data regarding the year of publication, the methods applied for indirect comparison, the number of studies, and the number of arms the studies included, as well as the total number of interventions involved in each network. From each network we extracted the trial data for the primary outcome (as stated in the text or, if this was unclear, defined as the first outcome presented). When both formats were reported, we preferred data presented in 2 Â 2 tables rather than as effect sizes and precisions. The extracted trial data include the name of each trial, the number of events, the sample size and the treatment in every arm of each trial included in the network.
Results

Database
We initially identified 817 relevant articles, and after the screening process we ended up with 40 networks. The full process for the selection of articles describing network analyses is shown in the flow chart of Figure 1 . The authors evaluated the assumption of inconsistency by using appropriate statistical methodology in 15 (38%) networks. Of these 15 networks, inconsistency for at least one comparison in the analysis was reported in 10 (67%). The most prevalent method (18%) of evaluating inconsistency was the loop-based approach. A large proportion of investigators (23%) seemed to be aware of the consistency assumption but used inappropriate methods to evaluate it, such as comparisons of direct and network estimates (Supplementary Table 1 , available as Supplementary data at IJE online).
Twenty-five (63%) networks used OR, 13 (33%) used RR, one (2%) used all three effect measures (OR, RR and RD), and one (2%) used a hazard ratio. In only seven publications (18%) did the authors explain why they chose the method that they used. The median number of studies per network was 23, ranging from 9 to 111. The number of treatments compared ranged from 4 to 17, with a median of 6. Thirty-three networks included three-arm trials and nine included four-arm trials. The number of included three-arm trials per network ranged from 0 to 12, whereas the number of included four-arm trials ranged from 0 to 6. The total number of loops obtained from the 40 networks was 303 and ranged from 1 to 70 per network. The characteristics of these networks are described in detail (Supplementary Table 2 , available as Supplementary data at IJE online).
Loop-specific approach
With regard to inconsistency under the four effect measures for binary data, 23 of the total of 303 loops were found to be inconsistent (8%) when analysed as OR, 26 (9%) as RRH, 29 (10%) as RRB and 29 (10%) as RD, for common within-loop heterogeneity ( 2 loop ) estimated with the DL method. Table 1 provides these results along with results under the assumption of common within-network heterogeneity ( 2 ntw ), which we discuss later. When we changed from one effect size to another under 2 loop , some consistent loops became inconsistent and vice versa. Such changes were mainly observed with the OR vs. RD and OR vs. RRB effect measures. Eleven (4%) loops that were consistent with the OR measure became inconsistent with the RD measure, whereas 5 (2%) loops that deviated from consistency with the OR became consistent when the RD measure was used (see Table 1 ). The percentage of inconsistent loops was comparable across the four effect measures (McNemar test under the within-loop heterogeneity; OR vs. RRH: P ¼ 0.505; OR vs. RRB: P ¼ 0.239; OR vs. RD: P ¼ 0.211). In Supplementary Table 3 (available as Supplementary data at IJE online) we provide the inconsistency estimates under the four scales for all loops, along with their standard errors and z-scores.
Our database includes 203 loops with at least one comparison being informed by a single study. Inconsistency was more likely to be found in such loops. For example, in the network of Elliot 39 we identified two inconsistent loops under the OR scale, which share the same comparison including only one study. It is possible that in such cases inconsistency is introduced by this particular study. Of the 203 loops in which at least one comparison was informed by a single study, 19 (9%) were found to be inconsistent under OR, whereas of the 100 remaining loops with comparisons including two or more studies, only 4 (4%) were inconsistent (P ¼ 0.154). The respective percentages of inconsistent loops for the other effect measures were 18 (9%) vs. 8 (8%) (P ¼ 0.972) under RRH, 21 (10%) vs. 8 (8%) (P ¼ 0.657) under RRB and 20 (10%) vs. 9 (9%) (P ¼ 0.977) under RD.
A similar picture appeared when a common within-network heterogeneity parameter ( 2 ntw ) was assumed, although the overall inconsistency rate dropped. Of the 303 loops obtained from the 40 networks in our study, we detected 16 (5%) inconsistent loops under OR, 19 (6%) under RRH, 18 (6%) under RRB and 16 (5%) under RD (see Table 1 ). In Supplementary Figure 1 Flow chart of the process of selecting articles describing network analyses In Figure 2 the P values for the loop-specific approach are presented under the common within-loop and the common within-network heterogeneity for the three pairs of effect measures of OR vs. RD, OR vs. RRH and OR vs. RRB. The two-sided P values are displayed on the fourth root scale. 14, 40 Among all six panels, agreement seems to be higher between OR and RRH, as seen by the lower degree of scatter around the equality line and a smaller number of discordant points. This is likely to be due to most outcomes being rare rather than common, so that OR is closer to RRH than to RRB. Heterogeneity estimates are in better agreement between OR and RRH (under the withinnetwork heterogeneity: mean
; under the within-loop heterogeneity: mean
In general, no substantial differences in inconsistency were observed with the effect measures.
With regard to inconsistency under different estimators for the heterogeneity parameter, Table 2 shows the number of inconsistent loops under the three estimators for 2 loop , as well as under the REML method for 2 ntw , using the OR effect measure. We observed that both the DL and REML methods led to a greater number of inconsistent loops than did the SJ method. This is because under certain circumstances the first two methods underestimate 2 , whereas SJ ntw . The solid diagonal line indicates equality, the dashed diagonal line is the regression line, and the dotted horizontal and vertical lines represent the P ¼ 0.05 threshold lines. Of the abbreviations in the figure, RD is the risk difference measure, RRH is the risk ratio for harmful outcomes, RRB is the risk ratio for beneficial outcomes, and OR is the odds ratio overestimates the true heterogeneity variance. As noted earlier, we observed that inconsistency was more frequent in loops that included comparisons informed by only one study (Table 2) . Under the assumption of a common within-loop heterogeneity, 19 (9%) of the 203 loops with at least one comparison informed by a single study were found to be inconsistent under DL, whereas only 4 (4%) of the remaining 100 loops were inconsistent (P ¼ 0.154). The respective percentages under the REML and SJ estimators are 18 (9%) versus 3 (3%) (P ¼ 0.099) and 12 (6%) versus 2 (2%) (P ¼ 0.217). However, assuming a common within-network heterogeneity, the respective inconsistent loops were 4 (2%) versus 12 (12%) (P ¼ 0.001) under REML. The evaluation of inconsistency assuming 2 ntw and REML in comparisons described by a single study decreases the inconsistency rate by 7% as compared with 2 loop . This is because the amount of within-network heterogeneity in most inconsistent loops, and particularly those that include at least one comparison informed by a single study, is larger than 2 loop . There was no evidence that inconsistency differs statistically among the three estimators when assuming a common within-loop heterogeneity (comparison of inconsistent loops with at least two studies per comparison: DL vs. REML: P ¼ 1; DL vs. SJ: P ¼ 0.679; SJ vs. REML: P ¼ 1; comparison of inconsistent loops with at least one comparison informed by a single study: DL vs. REML: P ¼ 1; DL vs. SJ: P ¼ 0.262; SJ vs. REML: P ¼ 0.343). However, inconsistency differs substantially between the common within-loop and the common within-network approach under the REML method (comparison of inconsistent loops with at least two studies per comparison: P ¼ 0.035; comparison of inconsistent loops with at least one comparison informed by a single study: P ¼ 0.003).
In Figure 3 we compare the estimated heterogeneity variance on the logarithmic scale using the DL, REML and SJ methods, showing that the SJ method is associated with larger values of heterogeneity variance, leading to fewer inconsistent loops than the other two methods. Among the three estimation methods, SJ is less likely to estimate 2 loop as being equal to zero (comparison of inconsistent loops when the within-loop heterogeneity is estimated equal to zero; DL vs. REML: P ¼ 0.586; DL vs. SJ: P ¼ 0.062; REML vs. SJ: P ¼ 0.011) (see Table 2 ).
For each loop, we compared the IF and its P value with the estimated heterogeneity variance for each loop ( 2 loop ) under the three estimators (see Appendix Figure 1 ). We observe that irrespective of the estimation method used, the magnitude of inconsistency increases slightly as the estimated heterogeneity variance increases. Conversely, lower values of the heterogeneity variance are associated with a greater chance of identifying IF with a 95% CI incompatible with zero, although the correlation coefficients between the P value or IF and the heterogeneity vari- Design-by-treatment interaction approach When the design-by-treatment-interaction approach was applied, the ML Wald tests for analyses of OR yielded 8 inconsistent networks among the 40 networks in our study (20%), whereas 11 (28%) of the networks were found to display inconsistency when analysed with each of the three effect measures RRH, RRB and RD (all pairwise comparisons between OR vs. RRH, RRB or RD for inconsistent networks under the ML estimator using the McNemar test produced P ¼ 0.371). The REML Wald test indicated 5 (13%), 6 (15%), 7 (17%) and 5 (12%) inconsistent networks under OR, RRH, RRB and RD, respectively (all pairwise comparisons between OR vs. RRH or RD for inconsistent networks under the REML estimator using the McNemar test produced P ¼ 1, whereas OR vs. RRB produced P ¼ 0.617) (see Supplementary Tables 6  and 7 , available as Supplementary data at IJE online).
In comparing the REML with the ML method, we found that the former yielded fewer inconsistent networks (12% to 17%, depending on the effect measure) than the latter (20% to 28%, depending on the effect measure), but there were no important differences (McNemar test under the comparison of ML estimator versus the REML estimator; OR: P ¼ 0.248; RRH: P ¼ 0.074; RRB: P ¼ 0.1336, RD: P ¼ 0.041) (see Supplementary Table 8 , available as Supplementary data at IJE online). This is probably because the ML method estimated slightly smaller values of the heterogeneity variance than did the REML method in almost all networks and under all effect sizes. For 14 networks (35%) we could not find any indication in the published articles that the authors evaluated the assumption of consistency. Four of these 14 networks were found to be inconsistent when we applied the design-by-treatment-interaction model using the REML method and the OR scale. That one in three of the authors of meta-analyses failed to examine consistency is a cause of concern, because conclusions based on combining direct and indirect evidence may not be valid when consistency does not hold.
In Figure 5 we present a plot of the heterogeneity variance estimated under the consistency and inconsistency models considering both the ML and REML methods under the OR effect measure. On average, the consistency models display greater heterogeneity than do the inconsistency models, probably accounting for inconsistency in the data.
Comparing loop-specific and design-by-treatment interaction model Table 3 shows a comparison of the number of inconsistent networks under the loop-specific approach with 2 ntw and under the design-by-treatmentinteraction approach when the OR is considered, assuming that if at least 5% of the loops are inconsistent then the network is inconsistent. The designby-treatment-interaction approach suggested fewer inconsistent networks (13%) than our ad hoc approach based on loop-specific assessments (20%). One network was inconsistent under the design-bytreatment interaction model while it was consistent with the loop-specific approach. That network was associated with design inconsistency, which was not accounted for in the loop-based method.
Discussion
Evaluation of consistency is an important task in network meta-analysis. 42 Protocols of network metaanalysis should ideally describe the methods for such an evaluation and outline the strategy that is to be followed if important inconsistency is detected. In this study we undertook a large-scale empirical evaluation of the prevalence of inconsistency, focusing both on closed loops of evidence within a network and on entire networks of interventions.
Our study confirms previous assumptions that heterogeneity plays an important role in the statistical detection of inconsistency. We found that lower heterogeneity was associated with higher rates of detected inconsistency, but that the estimated magnitude of inconsistency was less. This suggests that heterogeneity might account for some disagreement between various sources of evidence. The use of 2 ntw in the loop-specific approach provides a fair reflection of heterogeneity 42 and decreases the prevalence of inconsistency as compared with 2 loop . We further found that in some cases inconsistency might be reduced when changing the effect measure, but in general the three scales for dichotomous data present the same inconsistency rates. It has been shown that a poor choice of the measurement scale, i.e. analysing data on a 'preferred' scale rather than on the 'best' scale (a scale in which treatment effects can be assumed to be linear), can increase the probability of finding inconsistency.
14 It is advisable to choose the appropriate scale, relying on both the type of outcome data and mathematical properties, and to then transform the results to an alternative scale to aid interpretation.
Inconsistency was detected in 2% to 9% of the tested loops in our study, depending on the effect measure and heterogeneity estimation method used, and about one eighth of the networks were found to be inconsistent. We regard the two methods used in our study as complementary methods rather than competing ones. The identification of inconsistency in a network of evidence as a whole, through use of the design-bytreatment-interaction approach, provides an omnibus test and should lead to a careful examination of all parts of the network. It is advisable to use methods that can indicate which piece of evidence is responsible for this disagreement (e.g. the loop-based Table 3 Number of consistent networks that become inconsistent under the loop-specific and design-by-treatment-interaction approaches when the effect measure is the odds ratio a Loop-specific approach - The common within-network heterogeneity ( 2 ntw ) is estimated with the restricted maximum likelihood method. Under the loop-specific approach the networks that involve at least 5% inconsistent loops out of their total loops are considered as inconsistent. C, consistent networks; I, inconsistent networks. method used here, the node-splitting method 35 or the chi-squared test if possible 34 ) alongside the evaluation of the network as a whole. 33 If inconsistency is found, exploration of its possible causes is a key component of network meta-analysis and can raise research and communications standards by shedding light on the strengths and weaknesses of the body of evidence. 41 When few studies are included in a loop, the choice of heterogeneity estimator might influence inferences about inconsistency. The presence of a comparison informed by a single study was associated with a higher prevalence of inconsistency when 2 loop was used. This is in accord with findings in a recent simulation study 43 and with previous empirical evidence. 8 Such cases should prompt further investigation of the comparability of studies in the loop, although the finding might be indicative of errors in data extraction. The use of several techniques (e.g. predictive cross-validation) is probably required to decide whether the study is a statistical outlier. 44 Results of statistical tests should, however, be interpreted with caution: the absence of statistical inconsistency does not provide reassurance that the results of a network meta-analysis are valid. The assumption of consistency should always be evaluated conceptually by identifying possible effect modifiers that differ across studies. 41, 45 In the present study we evaluated articles included in PubMed and we restricted our analysis to dichotomous outcomes. Other network meta-analyses, such as those undertaken in technology appraisals for the National Institute for Health and Clinical Excellence (NICE) in the UK, are not included. We expect our findings about the choice of effect measure and statistical techniques to be generalizable, although it is unclear whether our findings about the prevalence of inconsistency are relevant to these settings. An empirical study for continuous outcomes will be needed to make inferences about possible differences in inconsistency between mean differences, standardized mean differences and ratios of means.
The findings of our study can be used to inform the development of strategies to detect and address statistical inconsistency. Results of the methods we examined appear to be sensitive to the estimation method and to assumptions made about heterogeneity. Consequently, caution is needed when overconservative or over-liberal estimation approaches are used for the heterogeneity parameter, and often a sensitivity analysis may be necessary. Further empirical evidence is needed to evaluate the performance of other methods to detect inconsistency not included in the present paper. More importantly, understanding of the power of both approaches under different assumptions about the heterogeneity parameter would benefit from an extensive simulation study.
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